Kristen Nooshin Ganjoo MD

Oncology•Palo Alto, CA

Sarcoma

Professor, Medicine - Oncology, Stanford University Medical Center

Join to View Full Profile

300 Pasteur DrPalo Alto, CA 94305
Phone+1 650-723-2325
Fax+1 650-498-5840

Clinical Expertise

Sarcomas

Education & Training

Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1997 - 2000
Indiana University School of MedicineResidency, Internal Medicine, 1994 - 1997
University of South Alabama College of MedicineClass of 1994

Certifications & Licensure

ID State Medical License 2025 - 2026
WA State Medical License 2023 - 2026
CA State Medical License 2003 - 2025
NV State Medical License 2022 - 2025
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms Start of enrollment: 2006 Sep 14
Completed
Phase 2
Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma Start of enrollment: 2006 Jul 01
Completed
Phase 1
Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma Start of enrollment: 2007 Mar 01
Completed
Phase 2
Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma Start of enrollment: 2008 Aug 01
Completed
Phase 1, Phase 2
Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma Start of enrollment: 2010 Feb 01
Terminated
Phase 2
Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT Start of enrollment: 2009 Feb 01
Terminated
Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
ACTIVE_NOT_RECRUITING
PHASE2
Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma Start of enrollment: 2011 May 01
Terminated
Phase 2
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01
Completed
Phase 2
Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Start of enrollment: 2014 Jan 01
Completed
Phase 3
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14
COMPLETED
PHASE3
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Start of enrollment: 2019 Feb 08
ACTIVE_NOT_RECRUITING
PHASE3
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Start of enrollment: 2019 Aug 13
ACTIVE_NOT_RECRUITING
PHASE2
Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma Start of enrollment: 2019 Oct 01
Completed
Phase 2
18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma Start of enrollment: 2021 Jan 28
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective...
Ted Kim, Clara Hao, Minggui Pan, Kristen N Ganjoo, Nam Q Bui
Diseases. 2025-03-11
2 citations
Histologic and Immunologic Factors Associated with Response to Immune Checkpoint Inhibitors in Advanced Sarcoma.
Alex Q Lee, Clara Hao, Minggui Pan, Kristen N Ganjoo, Nam Q Bui
Clinical Cancer Research. 2025-02-17
Genomic, Epigenomic, and Transcriptomic Inter- and Intratumor Heterogeneity in Desmoid Tumors.
Chelsea De Bellis, Sujay Vennam, Christopher Eeles, Pegah Rahimizadeh, Justin Cates
Clinical Cancer Research. 2025-01-06

Press Mentions

On the Treatment of Ovarian Cancer and STSOctober 19th, 2018
Getting a Second Opinion Can Help Ward off MisdiagnosisOctober 24th, 2023

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
Connective Tissue Oncology Society
Member